BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7016219)

  • 1. Mini-plasminogen: a mechanism for leukocyte modulation of plasminogen activation by urokinase.
    Moroz LA
    Blood; 1981 Jul; 58(1):97-104. PubMed ID: 7016219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different molecular forms of plasminogen and plasmin produced by urokinase in human plasma and their relation to protease inhibitors and lysis of fibrinogen and fibrin.
    Müllertz S
    Biochem J; 1974 Nov; 143(2):273-83. PubMed ID: 4282470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An elastase-dependent pathway of plasminogen activation.
    Machovich R; Owen WG
    Biochemistry; 1989 May; 28(10):4517-22. PubMed ID: 2504279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue plasminogen activator and urokinase mediate the binding of Glu-plasminogen to plasma fibrin I. Evidence for new binding sites in plasmin-degraded fibrin I.
    Harpel PC; Chang TS; Verderber E
    J Biol Chem; 1985 Apr; 260(7):4432-40. PubMed ID: 3156857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of alpha2-plasmin inhibitor on fibrin clot lysis. Its comparison with alpha2-macroglobulin.
    Aoki N; Moroi M; Tachiya K
    Thromb Haemost; 1978 Feb; 39(1):22-31. PubMed ID: 77050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.
    Glas-Greenwalt P; Kant KS; Allen C; Pollak VE
    J Lab Clin Med; 1984 Dec; 104(6):962-76. PubMed ID: 6239000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a synthetic carboxy-terminal peptide of alpha(2)-antiplasmin on urokinase-induced fibrinolysis.
    Lee KN; Jackson KW; McKee PA
    Thromb Res; 2002 Feb; 105(3):263-70. PubMed ID: 11927133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil proteases in plasminogen activation.
    Machovich R; Himer A; Owen WG
    Blood Coagul Fibrinolysis; 1990 Aug; 1(3):273-7. PubMed ID: 1715763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of the preactivation peptide in the two-stage mechanism of human plasminogen activation.
    Walther PJ; Hill RL; McKee PA
    J Biol Chem; 1975 Aug; 250(15):5926-33. PubMed ID: 1150667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of heparin and epsilon-aminocaproic acid in dogs on plasmin-125-I generation in response to urokinase injections and venous injury.
    Takeda Y; Parkhill TR; Nakabayashi M
    J Clin Invest; 1972 Oct; 51(10):2678-85. PubMed ID: 4262519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and characterization of alpha2-plasmin inhibitor from human plasma. A novel proteinase inhibitor which inhibits activator-induced clot lysis.
    Moroi M; Aoki N
    J Biol Chem; 1976 Oct; 251(19):5956-65. PubMed ID: 134998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences between neonates and adults in the urokinase-plasminogen activator (u-PA) pathway of the fibrinolytic system.
    Ries M; Zenker M; Gaffney PJ
    Thromb Res; 2000 Nov; 100(4):341-51. PubMed ID: 11113278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequence of formation of molecular forms of plasminogen and plasmin-inhibitor complexes in plasma activated by urokinase or tissue-type plasminogen activator.
    Thorsen S; Müllertz S; Suenson E; Kok P
    Biochem J; 1984 Oct; 223(1):179-87. PubMed ID: 6208894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rapid and sensitive 125I-fibrin solid-phase fibrinolytic assay for plasmin.
    Moroz LA; Gilmore NJ
    Blood; 1975 Oct; 46(4):543-53. PubMed ID: 126094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The fibrinolytic system in man.
    Collen D; Lijnen HR
    Crit Rev Oncol Hematol; 1986; 4(3):249-301. PubMed ID: 2420482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the activation mechanism of fibrinolytic enzyme system in plasma by human pancreatic elastase.
    Toki N; Takasugi S; Ishizu K; Sato H; Sumi H
    Thromb Haemost; 1982 Feb; 47(1):8-13. PubMed ID: 6176043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of kringles derived from human plasminogen on fibrinolysis in vitro.
    Sugiyama N; Iwamoto M; Abiko Y
    Thromb Res; 1987 Aug; 47(4):459-68. PubMed ID: 2821651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
    Wu JH; Diamond SL
    Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of action of fibrinolytic enzymes in vivo.
    Ambrus JL; Weber FJ; Ambrus CM
    J Med; 1979; 10(1-2):99-119. PubMed ID: 158624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinolysis in normal plasma and blood: evidence for significant mechanisms independent of the plasminogen-plasmin system.
    Moroz LA; Gilmore NJ
    Blood; 1976 Oct; 48(4):531-45. PubMed ID: 134751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.